Free Trial

Alpha Teknova (TKNO) Competitors

Alpha Teknova logo
$4.69 -0.11 (-2.29%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$4.70 +0.00 (+0.11%)
As of 08/15/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TKNO vs. CRON, TRVI, ELVN, ZYME, UPB, MLYS, IMNM, ATAI, URGN, and OCS

Should you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Cronos Group (CRON), Trevi Therapeutics (TRVI), Enliven Therapeutics (ELVN), Zymeworks (ZYME), Upstream Bio (UPB), Mineralys Therapeutics (MLYS), Immunome (IMNM), atai Life Sciences (ATAI), Urogen Pharma (URGN), and Oculis (OCS). These companies are all part of the "pharmaceutical products" industry.

Alpha Teknova vs. Its Competitors

Alpha Teknova (NASDAQ:TKNO) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

13.8% of Alpha Teknova shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 12.5% of Alpha Teknova shares are held by company insiders. Comparatively, 7.3% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cronos Group has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Teknova$37.74M6.65-$26.75M-$0.42-11.17
Cronos Group$117.61M7.72$41.08M$0.0547.40

Alpha Teknova presently has a consensus price target of $10.00, indicating a potential upside of 113.22%. Given Alpha Teknova's stronger consensus rating and higher probable upside, equities analysts clearly believe Alpha Teknova is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Teknova
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Cronos Group had 12 more articles in the media than Alpha Teknova. MarketBeat recorded 15 mentions for Cronos Group and 3 mentions for Alpha Teknova. Cronos Group's average media sentiment score of 0.86 beat Alpha Teknova's score of 0.46 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Teknova
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Cronos Group
5 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Alpha Teknova has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

Cronos Group has a net margin of 14.19% compared to Alpha Teknova's net margin of -55.24%. Cronos Group's return on equity of -3.78% beat Alpha Teknova's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Teknova-55.24% -26.51% -18.40%
Cronos Group 14.19%-3.78%-3.62%

Summary

Cronos Group beats Alpha Teknova on 11 of the 17 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TKNO vs. The Competition

MetricAlpha TeknovaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$256.87M$3.09B$5.66B$9.82B
Dividend YieldN/A2.23%3.79%4.07%
P/E Ratio-11.1720.3830.5825.12
Price / Sales6.65356.76462.42114.82
Price / CashN/A42.3037.4059.05
Price / Book3.308.659.096.18
Net Income-$26.75M-$54.65M$3.25B$264.89M
7 Day Performance10.87%6.58%7.32%4.18%
1 Month Performance8.82%7.54%5.41%1.99%
1 Year Performance-5.25%13.73%30.66%24.22%

Alpha Teknova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TKNO
Alpha Teknova
2.4071 of 5 stars
$4.69
-2.3%
$10.00
+113.2%
+16.7%$256.87M$37.74M-11.17240Gap Down
CRON
Cronos Group
1.089 of 5 stars
$2.67
+16.1%
N/A-1.7%$882.76M$117.61M53.40450High Trading Volume
TRVI
Trevi Therapeutics
3.0669 of 5 stars
$7.32
-1.3%
$20.38
+178.3%
+173.5%$870.31MN/A-17.4320Analyst Revision
ELVN
Enliven Therapeutics
2.7074 of 5 stars
$18.11
+2.4%
$41.20
+127.5%
-14.9%$868.03MN/A-9.4350News Coverage
Earnings Report
ZYME
Zymeworks
2.4824 of 5 stars
$12.44
+3.5%
$21.43
+72.3%
+36.8%$866.86M$122.87M-8.29460
UPB
Upstream Bio
1.8826 of 5 stars
$16.59
+3.7%
$56.50
+240.6%
N/A$862.55M$2.37M0.0038High Trading Volume
MLYS
Mineralys Therapeutics
3.2181 of 5 stars
$13.19
+1.5%
$32.25
+144.5%
+48.8%$847.28MN/A-3.5428News Coverage
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision
IMNM
Immunome
1.8243 of 5 stars
$9.66
-0.3%
$23.14
+139.6%
-26.3%$843.47M$9.04M-3.1440
ATAI
atai Life Sciences
3.0278 of 5 stars
$3.96
-4.1%
$11.25
+184.1%
+210.4%$827.39M$310K-4.3580News Coverage
Earnings Report
Gap Up
URGN
Urogen Pharma
4.6226 of 5 stars
$18.24
+2.8%
$31.43
+72.3%
+27.2%$820.96M$90.40M-5.49200Insider Trade
Analyst Revision
OCS
Oculis
3.085 of 5 stars
$17.97
-1.3%
$35.33
+96.6%
+50.4%$795.09M$780K-6.812Short Interest ↓

Related Companies and Tools


This page (NASDAQ:TKNO) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners